Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 4 days ago
Open | 9.40 |
High | 10.40 |
Low | 9.06 |
Mkt Cap | 2.24B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 8.60 |
52 Wk. Low | 4.92 |
52 Wk. High | 16.75 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 13.79M | 13.70% ▲ |
Net Income | -91.37M | - |
Diluted EPS | -0.39 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.41 | - |
Q1 2024 | -$0.42 | -$0.39 |
Q4 2023 | -$0.45 | -$0.42 |
S&P 500^GSPC | 5,222.54-0.14 (-0.00%) |
Dow 30^DJI | 39,455.92-56.92 (-0.14%) |
Nasdaq^IXIC | 16,387.19+46.32 (+0.28%) |
31.92+82.81% | |
5.65+94.29% | |
84.57+5.65% |